Fevertree Share Price (FEVR)

Now TAP catches a downgrade from BofA toUnderperform and PT $42 from $50.

RBC raises PT on FEVR to £10.30 from £9.00.

Things lining up here.

Diagio also downgraded on earnings yesterday. Alcoholic beverages are off a little so it’s all about FEV gaining more market share or an M&A situation.

For those in FEVR for possibility of take out TAP caught a downgrade in share price to $47 from $49 and reiteration Sell from Barclays after issuing softer than expected guidance Wednesday.

Diversification of TAP alcohol portfolio seems like an option to restoring growth.

FEV was over 1,400p 3 years ago. Today it is bigger, has more revenue, better bottom line coming, reduction of shares in issues. Yet the SP is lower - That kinda shows the potential upside if it just matches the old SP. GLA.

charts are largely nonsense - sp’s are driven by the dow, black swan events, m&a, tu’s & twice yearly results. this has a balance more weighted to an upside from general good trading, using molson in america’s to do the distribution, no more $7m severance costs on that change as one off. with molson acquiring nearly 10% of fev it looks like they see value and perhaps could be pulling together funds for take over that then puts all the sales margins in their pockets and they can consolidate fev distribution into uk, eu and the airlines (ba etc all use fev mixers on their flights). the only downsides are some small players in the same field, maybe global reduction in ****tail spending so less mixers required i’m big and long in fev. gla.